Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma

NCT00586014 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00586014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00586014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
May 31, 1997
Completion date
February 29, 2008
Enrollment
91 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma